Physician profile
Ellen Hui
NPI 1427497361
$3,276.62
in general payments reported to CMS, 2019-2025
15 companies · $730 in 2025
The $730 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $228 · 2021: $179 · 2022: $502 · 2023: $420 · 2024: $908 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,057.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $646.34 | 2022-2025 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $566.47 | 2019-2025 | Xelpros, Cequa |
| Alcon Vision LLC | $430.46 | 2023-2025 | Simbrinza, Rocklatan, Rhopressa |
| Bausch & Lomb Americas INC. | $237.47 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Harrow Eye, LLC | $213.14 | 2024-2025 | Vevye |
| Abbvie INC. | $180.90 | 2022-2025 | |
| Coopervision INC. | $163.10 | 2022-2025 | Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $161.82 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $161.57 | 2019-2023 | |
| Shire North American Group INC | $158.70 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $126.04 | 2024-2025 | Xdemvy |
| Allergan, INC. | $112.70 | 2020-2021 | |
| Eyevance Pharmaceuticals LLC | $54.25 | 2020-2021 | |
| Thea Pharma INC. | $44.66 | 2023-2024 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $19.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Hui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.